EMA TO ASSESS RESULTS OF EU PHARMACOEPIDEMIOLOGICAL RESEARCH PROJECT
February 9th, 2015
A five-year pharmacoepidemiological research project on the outcomes of therapeutics - aimed at strengthening the assessment of medicines - has wrapped up, with the European Medicines Agency (EMA) planning to review results this year, according to an EMA statement.The ‘Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium’ (PROTECT) project was launched to develop innovative methods to monitor the benefits and risks of medicines marketed in Europe.“PROTECT results may significantly influence practices ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.